Whoop, a leader in fitness wearables, is set to unveil a new blood testing panel aimed specifically at enhancing women's health through its Whoop Labs service. This initiative includes a fresh app feature that provides insights into hormonal fluctuations throughout menstrual cycles.
The newly developed panel comprises 11 critical blood biomarkers designed to shed light on various health aspects, including cycle regulation and hormonal transitions. Key biomarkers include Anti-Müllerian Hormone (AMH), Progesterone, Prolactin, Thyroid Peroxidase Antibodies (TPOAb), Free T4, Free T3, Leptin, Vitamin B12, Folate, Magnesium, and Phosphate.
Whoop emphasizes that analyzing these biomarkers can significantly enhance users' understanding of perimenopause, thyroid health, nutrient levels, and bone metabolic resilience, especially when integrated with data on physical activity, sleep patterns, and recovery.
This blood test will be available for purchase starting next month. Upon the launch of its blood testing service in September 2025, Whoop had an impressive waitlist of over 350,000 interested users.
Additionally, the app's new Hormonal Symptom Insights and Predictions feature utilizes historical data to model hormonal changes across menstrual cycles. This feature forecasts potential dates for upcoming periods, analyzes cycle lengths, and identifies individual symptom patterns.
Whoop's innovative approach allows users to correlate insights from this feature with lab results, categorizing biomarker data into 'optimal,' 'sufficient,' or 'out of range' classifications.
To further support this initiative, Whoop has released a comprehensive white paper detailing the modeling techniques behind these new features, offering deeper insights into menstrual cycle dynamics.
In response to increasing demand, fitness wearable companies are increasingly focusing on women's health. Recently, Oura, a smart ring manufacturer, launched an AI model tailored for women's health, along with a chatbot designed to provide health data insights.
Whoop has reported a remarkable 150% surge in female users over the past year, marking this demographic as its fastest-growing segment. Women are also engaging 30% more with the Whoop AI feature, indicating a strong interest in health tracking and insights.
This shift towards prioritizing women's health in wearable technology not only meets an underserved market demand but also paves the way for more personalized health solutions. As companies like Whoop and Oura innovate, the future of women's health monitoring looks promising, potentially transforming how women approach their health and wellness.